<DOC>
	<DOCNO>NCT01972555</DOCNO>
	<brief_summary>This single-center , open-label , randomize control trial . Patients schedule aortic valve replacement ( AVR ) Karolinska University Hospital Stockholm , Sweden eligible . Forty patient randomly assign either minimally invasive ( 20 patient ) conventional AVR ( 20 patient ) . CE-marked FDA-approved mechanical bioprosthetic aortic valve ( conventional stented sutureless bioprostheses ) implant . Transthoracic echocardiography perform surgery , day 1 , 4 , 40 . Echocardiographic parameter well preoperative clinical characteristic postoperative clinical outcome register . Routine blood sample perform pre- postoperatively . All available data collect prospectively . Informed consent obtain patient meet inclusion criterion initiation study-specific procedure .</brief_summary>
	<brief_title>Cardiac Function After Minimally Invasive Aortic Valve Implantation</brief_title>
	<detailed_description />
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<criteria>â‰¥ 18 year age Severe aortic stenosis define aortic valve area le 1 cm2 index area 0.6 cm2/m2 echocardiography Referred medically indicate aortic valve replacement Sinus rhythm Provide write informed consent Left ventricular ejection fraction le 0.45 Presence coexist severe valvular disorder Previous cardiac surgery Urgent emergent surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>